These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24687241)

  • 1. Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.
    Narvekar M; Xue HY; Eoh JY; Wong HL
    AAPS PharmSciTech; 2014 Aug; 15(4):822-33. PubMed ID: 24687241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-coated nanoparticles: Carrier platforms for hydrophobic water- and air-sensitive metallo-organic compounds.
    Valdeperez D; Wang T; Eußner JP; Weinert B; Hao J; Parak WJ; Dehnen S; Pelaz B
    Pharmacol Res; 2017 Mar; 117():261-266. PubMed ID: 28025103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug solubility in lipid nanocarriers: Influence of lipid matrix and available interfacial area.
    Göke K; Bunjes H
    Int J Pharm; 2017 Aug; 529(1-2):617-628. PubMed ID: 28705617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer chemotherapy with lipid-based nanocarriers.
    Liu D; Zhang N
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
    Lukyanov AN; Torchilin VP
    Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs.
    Choi KO; Choe J; Suh S; Ko S
    Molecules; 2016 May; 21(5):. PubMed ID: 27213324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric micelles: nanocarriers for cancer-targeted drug delivery.
    Zhang Y; Huang Y; Li S
    AAPS PharmSciTech; 2014 Aug; 15(4):862-71. PubMed ID: 24700296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoformulations of albendazole as effective anticancer and antiparasite agents.
    Movahedi F; Li L; Gu W; Xu ZP
    Nanomedicine (Lond); 2017 Oct; 12(20):2555-2574. PubMed ID: 28954575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
    Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
    Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
    Yasmin R; Tan A; Bremmell KE; Prestidge CA
    J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
    Narvekar M; Xue HY; Wong HL
    Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoformulations for combination or cascade anticancer therapy.
    Miao L; Guo S; Lin CM; Liu Q; Huang L
    Adv Drug Deliv Rev; 2017 Jun; 115():3-22. PubMed ID: 28624477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-Assisted Method Allows Assessment of Release of Hydrophobic Drugs From Nanocarriers.
    Gil D; Frank-Kamenetskii A; Barry J; Reukov V; Xiang Y; Das A; Varma AK; Kindy MS; Banik NL; Vertegel A
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28881095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multitechnique approach on adsorption, self-assembly and quercetin solubilization by Tetronics
    Pillai SA; Bharatiya B; Casas M; Lage EV; Sandez-Macho I; Pal H; Bahadur P
    Colloids Surf B Biointerfaces; 2016 Dec; 148():411-421. PubMed ID: 27639491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.
    Oliveira MS; Goulart GCA; Ferreira LAM; Carneiro G
    Expert Opin Drug Deliv; 2017 Aug; 14(8):983-995. PubMed ID: 27892713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.